- Delivery from India up to 20 days.
- Express delivery up to 7 days.
- Package of 30 tablets.
Favikast-200 Favipiravir buy at a bargain price in India
Favikast-200 Favipiravir is a new antiviral drug from the Indian pharmaceutical company Aprazer used for the treatment of severe forms of influenza and coronavirus (COVID-19).
The peculiarity of favipiravir as an antiviral agent is that the virus does not have resistance to favipiravir. The drug retains its therapeutic effect from the first to the last patient in a flu pandemic or other deadly viral infection. Favipiravir is expected to become an important therapeutic agent for severe flu and viral infections, when standard treatment is ineffective.
Toyama Chemical, a pharmaceutical company from Japan, created the active substance favipiravir in 2014 to treat the type A flu virus, including poultry, pigs, and COVID-19 strains. The drug favipiravir was tested in the context of the 2020 pandemic, which prompted the Indian manufacturer Aprazer to release the drug Favicast, approved for use in the fight against coronavirus in China, the United States, Italy and Russia.
Indications for use
When conservative treatment is ineffective, the main indication is the treatment of patients with flu.
The drug has activity against single-stranded RNA viruses: influenza, yellow fever, West Nile fever, viral flaviviridae and Arenaviridae, Bunyaviridae, arboviruses of the Togaviridae family of group A, aphthous fever. As an experimental treatment method, it has shown a high effect in the treatment of enterovirus and rift valley fever.
Currently, the drug Favipiravir is used as an experiment in the treatment of COVID-19 coronavirus. This drug affects strains resistant to treatment with amantadine, amantadine, oseltamivir, and zanamivir.
Contraindications
The drug Favipiravir is not used for the treatment of children, allergic reactions and pregnant women (including suspected pregnancy).
We recommend that you take extra care:
Hyperuricemia and gout (if the patient is also ill);
Patients with liver failure.
Side effect
Adverse reactions in the treatment fliperama rare.
However, there may be:
Allergic reactions;
Asthma, rhinitis, oropharyngeal pain;
Jaundice, liver disease, hyperbilirubinemia;
Stevens-Johnson syndrome, toxic epidermal necrolysis;
Kidney damage, neutropenia, increased white blood cells, leukopenia;
Convulsions, hallucinations, impaired consciousness;
Nausea, abdominal pain, gastritis, hemorrhagic colitis and vomiting;
Hypokalemia, hypertriglyceridemia and increased uric acid levels;
Hematuria, pigmentation, skin bruises, dizziness, eye pain, ecstasy, increased creatine kinase levels in the blood.
Special instruction
Special attention should be paid to the treatment of women and men of childbearing age. It is recommended to use an effective method of contraceptive barrier for 7 days after taking the drug.
Nursing women should stop breastfeeding.